Skip to main content
OpenTrials
Completed

NCT Number: NCT05721157

Osteoporotic Precisely Screening Using Chest Radiograph and Artificial Neural Network (OPSCAN)

Artificial Intelligence-assisted Diagnosis and Prognostication in Osteoporosis Using Chest X-ray

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Osteoporosis Bone Diseases Bone Diseases, Metabolic Fractures, Bone Metabolic Diseases Musculoskeletal Diseases Nutritional and Metabolic Diseases Osteoporotic Fractures Wounds and Injuries

Age range

40 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Tri-service general hospital

Taipei, 11490, Taiwan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients recieved at least 1 chest X-ray examination in 2022
  • More than 66% chest X-ray identified as high risk of osteoporosis by AI-CXR

Exclusion criteria

  • Patients with history of at least 1 dual energy x-ray absorptiometry (DXA)
  • Patients with history of osteoporosis or osteoportic fracture
  • Patients recieved prescription anti-osteoporotic treatment (excluding vitamin D or calcium)
  • Patients died before 01 Jan 2023

Treatment and study plan

AI-enabled Chest X-ray-based Screening Tool

Other

Primary care clinicians in the intervention group had access to the report, which displayed whether the AI-Chest X-ray result was positive or negative.The system will send a message to corresponding physicians if positive finding.

Primary outcomes

  1. newly diagnosed with osteoporosis

    Time frame: Within 180 days

    After performing an chest X-ray, the osteoporosis was followed.

Secondary outcomes

  1. initiation of DXA examination

    Time frame: Within 180 days

    After performing an chest X-ray, the osteoporosis was followed.

  2. initiation of anti-osteoporotic treatment

    Time frame: Within 180 days

    After performing an chest X-ray, the osteoporosis was followed.

Sponsors and collaborators

Lead sponsor

National Defense Medical Center, Taiwan

Other

Registry information

Official study title

Osteoporotic Precisely Screening Using Chest Radiograph and Artificial Neural Network (OPSCAN): a Randomized Controlled Trial

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Feb 9, 2023
Registry last updated
Jul 11, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.